Improve Cancer-related Cognitive Impairment
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT05864274
- Status
- Recruiting
Conditions
- Cancer-related Cognitive Difficulties
- Chemo-brain
- Chemotherapy Effect
- Gynecologic Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- Cognitive training application — DEVICEPatients will participate with a cognitive training application and undergo neurocognitive testing during and after chemotherapy.
Study Details
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.
Key Dates
- Start date
- Sep 1, 2024
- Status verified
- Nov 2025
- Primary completion
- Aug 1, 2027
- Completion
- Aug 1, 2027
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- No Intervention: OBSERVATIONPATIENTS WILL PARTICIPATE IN THE NEUROPSYCHOLOGY EVALUATION BUT WILL NOT USE THE COGNITIVE MOBILE TRAINING APPLICATION.
- Experimental: MOBILE COGNITIVE TRAINING APPThese patients will undergo neuropsychology evaluation and use the cognitive mobile training application
Primary Outcome Measure
Neurocognitive function [ Time Frame: From initiation of chemotherapy through 2 years ]
Central Contacts
- Teresa K Boitano, MD2059344986
- Rebecca Arend, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 |
Find similar trials in Birmingham, AL
By research site
Related Studies
- Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaPHASE1/PHASE2 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast CancerRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Mindfulness in Endometrial and Cervical CancerRecruiting · St. Louis University · St Louis, Missouri